New patent expiration for Astrazeneca Ab drug BYDUREON

Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…

The post New patent expiration for Astrazeneca Ab drug BYDUREON appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Do NOT follow this link or you will be banned from the site!